Impact of malglycemia on clinical outcomes in hospitalized patients with cancer: A review of the literature

Oncology Nursing Forum

Volumn 39, Issue 5, 2012, Pages 458-465

  Storey, Susan ^a   Von Ah, Diane ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

BLOOD; BONE MARROW TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; COMORBIDITY; DRUG TOXICITY; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LENGTH OF STAY; MORTALITY; NEOPLASM; NURSING; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SEPSIS; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; VEIN THROMBOSIS;

BONE MARROW TRANSPLANTATION; COMORBIDITY; DRUG TOXICITY; GLUCOCORTICOIDS; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INPATIENTS; LENGTH OF STAY; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84865997398     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/12.ONF.458-465     Document Type: Review

References (29)

1. Ali, N.A., O'Brien, J.M., Blum, W., Byrd, J.C., Klisovic, R.B., Marcucci, G.,. . Grever, M.R. (2007). Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer, 110, 96-102. doi:10.1002/cncr.22777 (Pubitemid 46986422)
2. Ali, N.A., O'Brien, J.M., Dungan, K., Phillips, G., Marsh, C.B., Lemeshow, S.,. . Preiser, J. (2008). Glucose variability and mortality in patients with sepsis. Critical Care Medicine, 36, 2316-2321. doi:10.1097/CCM.0b013e3181810378
3. Barone, B.B., Yeh, H.C., Snyder, C.F., Peairs, K.S., Stein, K.B., Derr, R.L.,. . Brancati, F.L. (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA, 300, 2754-2764. doi:10.1001/jama.2008.824
4. Benfield, T., Jensen, J.S., & Nordestgaard, B.G. (2007). Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia, 50, 549-554. doi:10.1007/s00125-006-0570-3 (Pubitemid 46215497)
5. Brunello, A., Kapoor, R., & Extermann, M. (2010). Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. American Journal of Clinical Oncology, 34, 293-296. doi:10.1097/COC.0b013e3181e1d0c0
6. Carr, M. (2001). Diabetes mellitus: A hypercoaguable state. Journal of Diabetes and Its Complications, 15, 44-54. doi:10.1016/S1056-8727(00)00132-X (Pubitemid 32203891)
7. Derr, R.L., Hsiao, V.C., & Saudek, C.D. (2008). Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care, 31, 1972-1977. doi:10.2337/dc08-0574
8. Derr, R.L., Ye, X., Islas, M.U., Desideri, S., Saudek, C.D., & Grossman, S.A. (2009). Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology, 27, 1082-1086. doi:10.1200/JCO.2008.19.1098
9. Dossett, L.A., Cao, H., Mowery, N.T., Dortch, M.J., Morris, J.M., & May, A.K. (2008). Blood glucose variability is associated with mortality in the surgical intensive care unit. American Surgeon, 74, 679-685.
10. Egi, M., Bellomo, R., Stachowski, E., French, C.J., & Hart, G. (2006). Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology, 105, 244-252. doi:10.1097/00000542- 200608000-00006 (Pubitemid 44148168)
11. Fugi, S., Kim, S., Mori, S., Kamiya, S., Yoshimura, K., Yokoyama, H.,. . Fukuda, T. (2009). Intensive glucose control after allogeneic hematopoietic stem cell transplantation: A retrospective matched-cohort study. Bone Marrow Transplantation, 44, 105-111. doi:10.1038/bmt.2008.431
12. Fugi, S., Kim, S.W., Mori, S., Fukuda, T., Kamiya, S., Yamasaki, S.,. . Takaue, Y. (2007). Hyperglycemia during the neutropenia period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation, 84, 814-820. doi:10.1097/01.tp.0000296482.50994.1c (Pubitemid 351338940)
13. Garg, R., Bhutani, H., Alyea, E., & Pendergrass, M. (2007). Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation. Diabetes Care, 30, 993-994. doi:10.2337/dc06-2563 (Pubitemid 46556599)
14. Hammer, M.J., Casper, C., Gooley, T.A., O'Donnell, P.V., Boeckh, M., & Hirsch, I.B. (2009). The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biology of Blood and Marrow Transplantation, 15, 344-351. doi:10.1016/j.bbmt.2008.12.488
15. Hardy, S.J., Nowacki, A.S., Bertin, M., & Weil, R.J. (2010). Absence of an association between glucose levels and surgical site infections in patients undergoing craniotomies for brain tumors. Journal of Neurosurgery, 113, 161-166. doi:10.3171/2010.2.JNS09950
16. Hermanides, J., Vriesendorp, T.M., Bosman, R.J., Zandstra, D.F., Hoekstra, J.B., & DeVries, J.H. (2010). Glucose variability is associated with intensive care unit mortality. Critical Care Medicine, 38, 838-842. doi:10.1097/CCM.0b013e3181cc4be9
17. Kent, T., Soukup, V., & Fabian, R. (2001). Heterogeneity affecting outcome from acute stroke therapy: Making reperfusion worse. Stroke, 32, 2318-2327. doi:10.1161/ hs1001.096588 (Pubitemid 32954803)
18. Kreutziger, J., Schlaepfer, J., Wenzel, V., & Constantinescu, M.A. (2009). The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. Journal of Trauma, 67, 704-708. doi:10.1097/TA.0b013e3181b22e37
19. Krinsley, J.S. (2004). Effect of intense glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings, 79, 992-1000. doi:10.4065/ 79.8.992 (Pubitemid 39007018)
20. Marchant, M.H., Viens, N.A., Cook, S., Vail, T.P., & Bolognesi, M.P. (2009). The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. Journal of Bone and Joint Surgery, 91, 1621-1629. doi:10.1097/CCM.0b013e3181810378
21. Melynk, B.M. (2004). Integrating levels of evidence into clinical decision making. Pediatric Nursing, 30, 323-324.
22. Mraovic, B., Hipzer, B.R., Epstein, R.H., Pequignot, E.C., Parvizi, J., & Joseph, J.I. (2010). Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. Journal of Arthroplasty, 25, 64-70. doi:10.1016/j.arth.2008.10.002
23. National Cancer Institute. (2006). Common Toxicity Criteria for Adverse Events [v3.0]. Retrieved from http://ctep.cancer.gov/protocoldevelopment/ electronic-applications/docs/ctcaev3.pdf
24. Sheean, P.M., Freels, S.A., Helton, W.S., & Braunshweig, C.A. (2006). Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 656-664. doi:10.1016/j.bbmt.2006.01.010
25. Umpierrez, G.E., Isaacs, S.D., Bazargan, N., You, X., Thaler, L.M., & Kitababchi, A.E. (2002). Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 978-982. (Pubitemid 36121050)
26. Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninickx, F., Schetz, M.,. . Bouillon, R. (2001). Intensive insulin therapy in critically ill patients. New England Journal of Medicine, 345, 1359-1367. doi:10.1210/jc.2009-0663
27. Von Ah, D., Kang, D.H., & Carpenter, J. (2008). Predictors of cancer-related fatigue in women with breast cancer prior to, during, and after adjuvant therapy. Cancer Nursing, 31, 134-144. doi:10.1097/01.NCC.0000305704. 84164.54
28. Weiser, M.A., Cabanillas, M.E., Konopleva, M., Thomas, D.A., Pierce, S.A., Escalante, C.P.,. . O'Brien, S.M. (2004). Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate cytarabine regimen. Cancer, 100, 1179-1185. doi:10.1002/cncr.20071 (Pubitemid 38325945)
29. Zeng, L., Biernacka, K.M., Holly, J.M., Jarrett, C., Morrison, A.A., Morgan, A.,. . Perks, C.M. (2010). Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: The role of fatty acid synthase. Endocrine-Related Cancer, 17, 539. doi:10.1677/ERC-09-0221